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Clinical  and  histopathological  observations  suggest  that  the  mucosal  immune 
system  plays a  role in  the pathogenesis of some  forms  of human  immune  complex 
glomerulonephritis (1,  2).  For example, many studies of idiopathic recurrent  hema- 
turia  (Berger's nephropathy)  and  glomerulonephritis associated with  anaphylactoid 
purpura  (Henoch-Sch6nlein  syndrome),  in  which  immunoglobulin  A  (IgA)  is  the 
predominant or sole Ig deposited in glomeruli, report the clinical association of viral- 
like respiratory and gastrointestinal syndromes  (2-13). Also, much  of the body's IgA 
is  derived  from  gut  and  respiratory-associated  lymphoid  tissue  (14-16),  and  an 
expansion of specific IgA synthesizing cells in  mesenteric lymph nodes, spleen, and 
secretory mucosae and a  significant elevation of IgA antibody in serum and exocrine 
fluids  can  occur  in  response  to  oral  immunization  (14-21).  These  considerations 
prompted  the  hypothesis  that  IgA  nephropathy  can  follow  a  mucosal  immune 
response, such as might result from an infection. To test this hypothesis experimentally, 
protein antigens were presented to mice in their drinking water for  14 wk.  Kidneys 
from  immunized  and  nonimmunized  mice  were  then  examined  for  evidence  of 
immune deposits. 
Materials and  Methods 
Animals.  Female BALB/cAnNCrlBR mice, 6-8 wk old, were obtained from  the Charles 
River Breeding Laboratories, Inc., Wilmington, MA. 
Immunization.  Ovalbumin  (OVA), 1 bovine gamma globulin (BGG)  (Sigma Chemical Co., 
St. Louis, MO), and horse spleen ferritin (FER) (Calbiochem-Behring Corp., American Hoechst 
Corp., San Diego, CA) were used as antigens. Mice (four to six per group) received 100 mg/dl 
OVA  (one group),  FER  (one group), or BGG  (two  groups), or water alone  (control;  three 
groups) prepared fresh in acidified water (6 mM HC1) on alternate days for 14 wk. 
Sacrifice and  Tissue Processing.  After completion of oral immunization, all mice were main- 
tained for an additional 2 d  with free access to food and plain acidified water. Under ether 
anesthesia, mice were bled by transection of the right axillary artery. Sera were frozen at -70°C 
until assayed (described below). Portions of renal cortex were processed for light and electron 
microscopy as previously described (22). Slices of the remainder of the kidneys and segments of 
small intestine, liver, spleen, lung/bronchus, and skin were snap frozen and stored at -70°C. 
Cryostat sections 4-6/~m thick on glass slides were air-dried for 5 min and stored at -70°C for 
immunofluorescence. 
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Antisera.  Fluoresceinated goat antisera to mouse IgA, IgM and C3 were obtained from N.L. 
Cappel Laboratories Inc., Cochranville, PA. Fluoresceinated goat antiserum to mouse IgG was 
obtained from Calbiochem-Behring  Corp. Preparation of rabbit antisera specific for mouse IgA 
and IgG has been described (23). Rabbit anti-mouse IgM was obtained from N.L.  Cappel 
Laboratories Inc. 
Rabbit anti-FER, anti-OVA, and anti-BGG were prepared by immunization with antigen 
in complete Freund's adjuvant (19, 22). The  anti-BGG was  absorbed with  Sepharose  4B- 
conjugated normal BALB/c serum to eliminate cross-reactivity with mouse IgG. Each final 
antibody preparation reacted  only with  its respective immunogen and not with  the other 
antigens, mouse serum proteins, or MOPC-315 ascites  fluid, when tested by double immuno- 
diffusion. Rabbit anti-rat secretory component and rabbit anti-mouse J  chain were kindly 
provided by Dr. Brian Underdown and Dr. Reuben Baumal, respectively. Rhodaminated goat 
anti-rabbit IgG and peroxidase-conjugated goat  anti-rabbit IgG were obtained from  Miles 
Laboratories Inc., Research Products Div., Elkhart, IN. Both goat antisera reacted with all of 
the rabbit sera,  but not with mouse serum, when tested by double immunodiffusion. Indirect 
immunofluorescence staining of normal BALB/c  kidney with  each  of the  rabbit  antisera 
described  above,  followed  by  rhodaminated  goat  anti-rabbit IgG,  was  negative.  Indirect 
immunofluorescence on sections of mouse intestine with rabbit anti-rat secretory component 
and rhodaminated goat anti-rabbit IgG revealed bright staining of the apical margins of the 
lining epithelial cells. Similar sections incubated with rabbit anti-mouse J  chain followed  by 
rhodaminated goat anti-rabbit IgG revealed staining of plasma cells in the lamina propria and 
lining epithelial cells. 
Immunofluorescence.  All immunofluorescence  was performed as described previously (19, 22). 
Incubations with antisera were for 30 min each except as noted. Sections of lung, liver, small 
intestine, and spleen were examined by a double label sandwich technique to assess antibody 
to FER, OVA, or BGG in plasma ceils which were making IgA, IgG, or IgM by the binding  of 
antigen as  previously described  (19),  using 100 #g/ml of antigen and appropriate antisera 
diluted  1:10. In the  intestine and bronchus, IgA-producing cells  (green fluorescence only), 
specific IgA-producing cells  (both green and red fluorescence),  and non-IgA antigen-binding 
cells (red fluorescence only) were counted in each of three different 400 ×  fields from each of 
three different mice immunized with each of the three antigens (27 fields in all). The arithmetic 
means of the 9 fields  examined for antigen binding for each of the three antigens, and the 
arithmetic mean of the 27 fields examined for IgA-producing cells were calculated. Sections of 
skin were stained for IgA with fluoresceinated goat anti-mouse IgA. 
Sections of kidney were  stained  by  the  direct  method  for  mouse  IgA,  IgG,  IgM,  and 
complement (C3)  using fluorescein-conjugated antisera diluted  1:10. In addition, sections of 
kidney were  stained for the presence of antigen with rabbit anti-OVA, rabbit anti-FER, or 
rabbit anti-BGG (each  diluted 1:10) followed  by rhodaminated goat anti-rabbit IgG (diluted 
1:80). Because of the weak staining for antigen by indirect immunofluorescence  with a standard 
30 min incubation with the primary (rabbit anti-antigen) antiserum, indirect stains of kidney 
sections to detect antigen were done with a  120-rain incubation of the primary antiserum. The 
weak staining for antigen with a 30-min incubation of primary antiserum afforded a means to 
assess  the  presence of specific  antibody (by antigen binding) in the  kidney sections by a 
sandwich technique. This consisted of incubating  sections with 100 #g/ml of antigen, followed 
by rabbit anti-antigen (for 30 min), and finally rhodaminated goat anti-rabbit IgG. 
Kidney sections from six BGG immunized mice and six nonimmunized  control mice were 
each stained forJ chain with rabbit anti-mouseJ chain (diluted 1:10) followed by rhodaminated 
goat  anti-rabbit IgG (1:80),  and for  the secretory component with rabbit anti-rat secretory 
component (diluted 1:15) followed  by rhodaminated goat anti-rabbit Ig~ (1:80). 
Coded sections were examined independently by two observers and the intensity of staining 
was scored as 0-3+. In the occasional instances when the scores from the two observers differed, 
the section was reexamined (prior to decoding) by both observers and a score was agreed upon. 
Mice were classified as negative if the score was 0 or trace, and positive if 1+ or greater. 
Light  Microscopy.  Coded  sections  of paraffin-embedded, formalin-fixed kidney  from  13 
immunized and 12 nonimmunized  mice were examined independently  by two observers. 
Electron Microscopy.  Coded  grids  from  15  immunized and  14  nonimmunized mice were 574  EXPERIMENTAL  lgA NEPHROPATHY 
examined and photographed in a Zeiss EM  10 microscope (Carl Zeiss, Inc., NY) and scored as 
positive (definite electron-dense deposits present) or negative (no electron-dense deposits ob- 
served). 
Serum Antibody Levels.  Assays of the specific antibody of each major isotype and of the total 
Ig of each isotype in immunized and nonimmunized mice were performed by adaptations of 
the enzyme-linked immunosorbent assay (ELISA) (24, 25). Polyvinylchloride microtiter dishes 
(Dynatech Laboratories, Inc., Dynatech Corp., Alexandria, VA) were coated with a  1 /~g/ml 
solution of one of the three protein antigens (to assay for antibody) or with goat anti-mouse 
IgA, IgG, or IgM (to assay for total Ig of a particular isotype). After three washes, sera diluted 
in  1%  bovine serum  albumin  (BSA)-0.05% Tween  20-phosphate-buffered saline (PBS)  were 
incubated at  ambient  temperature  for 2  h,  with  three washes between  incubations,  in  the 
following sequence: sample (diluted  1:100)  or standard mouse serum, isotype-specific rabbit 
anti-mouse serum  (diluted  1:500),  and  peroxidase-conjugated goat  anti-rabbit IgG  (diluted 
1:1,000).  Enzyme activity was  detected in the wells by the addition to each well of 150  ~1 
substrate solution (prepared by dissolving 10 mg of 0-phenylenediamine [Sigma Chemical Co.] 
in 100 ml distilled water and adding 10/.tl 30% H202 [Fisher Scientific Co., Pittsburgh, PA] just 
before use). An Artek model 210 v-beam reader coupled to an Apple II microcomputer (Artek 
Systems Corp., Farmingdale, NY),  kindly made available by Dr.  Zoltan Ovary  (New York 
University Medical Center, New York), was used to read the plates. The arithmetic mean of 
the difference in optical densities at 45  and  0  min  in the duplicate wells was  taken  as the 
concentration of antibody in arbitrary units. Standard curves were constructed with the values 
from serially diluted arbitrary standard sera (rabbit anti-OVA, rabbit anti-BGG, rabbit anti- 
FER)  and  purified  MOPC-315  IgA, a  purified  monoclonal  mouse  IgG  (44D)  (26),  and  a 
purified monoclonal mouse IgM  (DLK 23603),  the last two kindly provided by Dr.  Victor 
Nussenzweig (New York University Medical Center). All the data points fell within the linear 
portions of the standard curves. 
Hematuria and Proteinuria.  At the time of killing, urine was collected from each mouse by 
applying pressure to the suprapubic triangle. Drops of urine were placed upon  Bili-Labstix 
(Miles Laboratories, Ames Division, Elkhart, IN) and semiquantitated for protein and blood. 
BGG immunized mice and nonimmunized control mice (6 per group) were placed in metabolic 
cages overnight at weekly intervals starting 4 wk before killing. Urine collected under mineral 
oil was tested for protein and blood with Bili-Labstix. 
Results 
Immunofluorescence in Nonrenal  Tissues.  In both intestines and bronchi the number of 
specific  IgA-producing cells  in  immunized  mice  was  significantly greater  than  in 
nonimmunized  mice,  whereas  the  total  number  of  IgA-producing  cells  and  the 
number  of specific cells not  producing  IgA were  not  significantly different  in  the 
immunized and nonimmunized groups (Table I). The binding of antigens other than 
the  immunogen,  e.g.,  OVA  or  FER  binding  in  BGG-immunized  mice,  was  not 
different in immunized vs.  nonimmunized  groups  (three to four cells per ten 400  × 
fields). These findings indicate that a specific IgA immune response occurred in orally 
immunized mice. 
Sections of liver showed weak fluorescence for IgA around liver cell membranes in 
both immunized and nonimmunized mice. In sections of spleen there were numerous 
IgA-posit~ve cells, about  equal  in  number  in  immunized  and  nonimmunized  mice. 
Rare antigen binding was demonstrable in plasma cells in the spleen in immunized 
but  not  in  nonimmunized  mice.  IgA was  always associated with  cells in  the  liver, 
spleen and gut;  there were no extracellular deposits. Sections of skin did not exhibit 
any staining for IgA. 
Serum  Antibody  Levels.  The  mean  serum  IgA  antibody  levels  against  the  three 
antigens are summarized in Table II. In all cases the mean IgA antibody level against EMANCIPATOR, GALLO, AND LAMM 
TABLE  I 
Quantification of Plasma Cells in Intestinal and Bronchial Lamina Propria in 
Immunized and Nonimmunized Mice* 
Specific 
Total IgA  Specific  IgA  non-lgA 
Immunized mice 
Intestine  148 ± 6.0  28 ± 2.7:~  10 ±  1.0 
Bronchus  56 ± 2.2  6.2 ±  1.3§  ND¶ 
Nonimmunized mice 
Intestine  162 ± 6.7  3.2 ± 0.63  12 ±  1.4 
Bronchus  52 -l- 1.9  2.5 ± 0.70  ND¶ 
* Expressed as 10 times the mean number per 400 × field ±  1 SE. 
:~ Different from nonimmunized mice (P < 0.01). 
§ Different from nonimmunized mice (P < 0.05). 
¶ Not done. 
TABLE II 
Mean Serum IgA Antibody Levels * 
Immunogen  Anti-OVA  Anti-FER  Anti-BGG 
OVA  87.1 ± 8.45~  20.3 ± 6.86  49.5 ± 8.24 
FER  47.1 ±  12.8  34.1 ± 4.63  t  42.0 ± 6.75 
BGG  22.0 ±  1.90  18.0 ± 2.96  126.6 ±  10.3"1" 
CON  25.8 ± 5.40  21.0 ± 4.57  44.7 ± 3.02 
*  Means of all sera in duplicate +  1  SE (arbitrary units). 
:~ Different from the anti-antigen level in all other groups in the same column 
(P < 0.001). 
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the particular immunogen in immunized mice was significantly different from  the 
mean  antibody level  against  the  immunogen in  nonimmunized mice  or  in  mice 
immunized with the other antigens (P <  0.001). These values, when interpolated into 
each particular standard curve, indicate 16-32-fold, 16-fold, and 8-16-fold increases 
in specific IgA antibody in mice orally immunized with BGG, OVA, or FER when 
compared  with  nonimmunized controls.  There was  no  difference  in  levels of IgA 
antibody to antigens other than the particular immunogen in immunized vs. nonim- 
munized mice, and there was no significant difference in specific IgG or IgM antibody, 
or  total  IgA,  IgG,  or  IgM  between immunized and nonimmunized groups.  These 
data, indicating a rise in specific IgA antibody in serum, correlate with the expansion 
of specific IgA-producing plasma cells observed in mucosae. 
Renal Immunofluorescence and Electron Microscopy. Table III summarizes the immunoflu- 
orescence for IgA and the ultra.structural findings in glomeruli. There was mesangial 
accumulation of IgA in 14 of 19 immunized mice, but in only 2 of 15 nonimmunized 
control mice  (X  2 ffi  9.95;  0.001  <  P  <  0.01).  In positive mice the  staining among 
glomeruli was uniform throughout the cortex and deposits were restricted to mesangial 
areas (Fig. 1 A). In contrast, there was no difference in the weak staining observed for 
IgG or IgM between immunized and nonimmunized groups.  Deposits of C3  could 
not be demonstrated in any animal. 
Whereas  sections of kidney showed  only weak  fluorescence staining for  antigen 
when  incubated with  the  primary antiserum for  30  min, sections incubated with 
primary antiserum for 120 min demonstrated uniform diffuse mesangial fluorescence 576  EXPERIMENTAL  IgA NEPHROPATHY 
TABLE III 
Correlation of Immunofluorescence  for IgA and Electron-dense Deposits in Glomeruli 
Immunogen 
Increased  Total 
serum IgA  number of 
antibody*  mice 
Positive IgA 
immunofluorescence:~ 
Negative IgA 
immunofluorescence 
EM  EM  EM  EM  No EM  No EM  positive  negative  positive  negative 
BGG  +  8  6  1  0  0  1  0 
-  3  1  2  0  0  0  0 
OVA  +  3  1  0  l  0  0  l 
-  1  0  0  0  0  0  1 
FER  +  0  0  0  0  0  0  0 
-  4  1  1  0  0  0  2 
CON  +  0  0  0  0  0  0  0 
-  15  1  1  0  0  12  1 
* + indicates a mean serum antibody level that is ~  2 SD greater than in nonimmunized mice. 
:~ Positive immunofluorescence  for IgA is ~ 1  + score by both observers. 
FIG.  1.  Glomeruli from mice orally immunized with BGG show mesangial immunofluorescence 
staining for mouse IgA (A), BGG (B), and mouse  J chain (C), × 400. 
for antigen in  14 of 16 immunized but only 5  of 14 nonimmunized mice examined 
(X  z =  6.54;  0.01  <  P  <  0.02)  (Fig.  1 B).  There was  a  tendency towards  an  inverse 
correlation between the intensity of staining for IgA and that  for antigen, although 
this did not attain significance  when tested by the rank-correlation method of Kendall. 
The presence of BGG in OVA- and FER-immunized  mice (1 of S) was not significantly 
different from that seen in nonimmunized control mice (3 of 15).  Because of positive 
staining for BGG in occasional mice not immunized with BGG, the rabbit anti-BGG 
antiserum was absorbed with Sepharose-conjugated BGG. This absorption eliminated 
staining in all BGG-positive mice, including those not actively immunized with BGG. 
The sandwich technique used to investigate the antigen-binding  specificity of the 
deposited mesangial IgA (see  Methods and Materials) revealed consistently brighter 
intensity in 12 of the 15 immunized mice examined but in only 4 of 15 nonimmunized 
mice when compared with parallel sections preincubated with saline and subsequently 
stained for antigen with 30 min incubation of primary antiserum (X  3  =  6.56; 0.01  < 
P <  0.02). Binding by the sandwich technique was not seen for protein antigens other 
than the respective immunogen, except  in the case of one OVA-immunized mouse 
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Fla.  2.  Electron micrograph of a portion of a glomerulus from a  mouse that had been orally 
immunized  with  OVA.  Electron-dense deposits  (left-hand  pair  of arrows) are  present in  the 
mesangium but not in peripheral capillary wall (right-hand pair of arrows). × 8,800. 
Of six  BGG-immunized  mice,  five revealed  mesangial  deposition  of J  chain  in  a 
pattern  similar  to that  seen  for IgA and  antigen  (Fig.  1 C)  whereas  none of the six 
nonimmunized mice showed staining for J  chain (X  2 =  5.49; 0.01 <  P <  0.02). All the 
mice had trace mesangial staining for IgM, but staining for J  chain was only observed 
in sections which revealed IgA. No secretory component was demonstrable in the six 
BGG immunized mice or five nonimmunized controls examined. 
Electron-dense  deposits  were  observed  within  mesangial  and  paramesangial  sites 
(Fig. 2) but not in peripheral capillary walls in 9 of 14 immunized mice examined by 
electron  microscopy  (Table  III).  Of the  14  nonimmunized  control  mice  examined 
ultrastructurally,  only one had  electron-dense  deposits  (X  ~  =  7.6;  0.01  <: P  <  0.02). 
There  was  a  close  correlation  between  mesangial  deposition  of IgA as  assessed  by 
immunofluorescence and  electron  microscopic deposits:  10 of 15  mice examined  by 
electron microscope in which deposits of IgA were found had electron-dense deposits, 
whereas  none of the  13 mice that  were negative for IgA had  deposits  demonstrable 
ultrastructurally  (X  ~ =  10.7; P  <  0.001). 578  EXPERIMENTAL IgA NEPHROPATHY 
Light Microscopy.  No changes were observed by light microscopy in any animal. 
Hematuria  and Proteinuria.  Urine  from mice studied  periodically by placement  in 
metabolic cages revealed sporadic proteinuria but no hematuria in both immunized 
and control groups, nor could hematuria or proteinuria be consistently demonstrated 
in any group at the time of killing. 
Discussion 
The  major  finding  that  emerged  from  these  studies  is  that  orally  administered 
antigen can induce a specific IgA mucosal immune response that results in glomerular 
mesangial  deposits  of specific  IgA  antibody  and  antigen,  which  is  indicative  of 
immune  complexes.  Several  observations  support  this  conclusion.  First,  there  was 
codeposition  of specific IgA antibody and  immunogen in  the same distribution  by 
immunofluorescence,  plus  mesangial  electron-dense  deposits  in  the  glomeruli  of 
immunized  mice. These  findings  were significantly different  from those  in  nonim- 
munized mice. Second, the specific immunogen, but neither of the other two antigens 
used, was demonstrated in the glomeruli of each immunized group. Third, incubation 
of tissue sections with each of the three different antigens indicated  that the immu- 
nogen  for each  group  was  the only one which  bound  to glomeruli  containing  IgA 
antibody.  Thus,  not  only was  the  deposition  of IgA statistically  more  frequent  in 
immunized  than  in  nonimmunized  mice,  but  antigen  deposition  and  antibody 
specificity were dependent upon the particular immunogen used. If  the demonstration 
of antigen by immunofluorescence had been due to other factors, such as nonspecific 
binding of the protein antigens to deposited immunoglobulin or altered renal tissue, 
this  specificity  for  the  particular  immunogen  would  be  difficult  to  explain.  We 
speculate that the correlation of active mucosal immunity with IgA glomerulopathy 
in this model has relevance to human IgA nephropathies, especially those associated 
with viral syndromes. 
The association of glomerular immune complexes with  specific IgA antibody  in 
serum and the expansion of specific IgA producing plasma cells in  the mucosae of 
immunized  but  not  nonimmunized  mice  clearly  supports  a  role  for  the  secretory 
immune system in the pathogenesis of this model. The immune response was restricted 
in  terms of immunoglobulin  isotype, in  that  the expansion of specific plasma cells, 
elevated serum antibody levels, and  renal  deposits were all observed in  association 
with only one Ig class, namely IgA. 
The fact that  in  the kidneys of immunized animals it was easier to demonstrate 
binding of exogenous antigen to sections than to demonstrate antigen already present 
suggests  that  the  deposits  were  in  antibody  excess.  However,  initial  deposition  of 
serum immune complexes in glomeruli is in general favored by antigen excess (27), so 
that  it  is  a  good  possibility  that  the  antigen  demonstrated  was  largely  originally 
deposited  relatively early during  the  immune response when circulating complexes 
would  be expected to be in antigen  excess. As the secretory immune response then 
gained momentum, absorption of additional antigen from the lumen of the intestine 
would diminish. During the course of the continuing mucosal immune response some 
of the newly synthesized IgA that directly entered the circulation could combine with 
complexes already in the glomeruli, and convert them to antibody excess. In a sense, 
if this  concept  is  correct,  IgA nephropathy  would  be  a  subversion  of the  natural 
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antibody  is  encountering  antigen  inside  the  body  (in  the  case of an  intramucosal 
infection, for example) instead of intralumenally outside the body proper, and thus 
the resulting immune complexes become noxious rather than being simply excreted 
without ever gaining access to the interior of the body. 
The site of the initial formation of immune complexes in the model is not absolutely 
certain. Complexes could form in the lumen of the gut, in some compartment of the 
extracellular fluid, or possibly in situ within  the mesangial matrix itself. It is likely, 
however,  that  the  complexes  form  in  the  extracellular  fluid.  The  predominant 
antibody in complexes formed within  the intestinal  lumen would  be secretory IgA, 
with  a  molecular weight  of 400,000  and  four combining sites  for antigen  in  each 
molecule. Complexes formed with secretory IgA would therefore be large. Although 
absorption of immune complexes formed at extreme antigen excess has been described 
with IgG immune complexes (28), in an orally primed host, the absorption of antigen, 
free or bound in immune complexes, was significantly reduced. In addition, the lack 
of secretory component in mice with IgA glomerular deposits is evidence against the 
absorption of secretory IgA immune complexes from the gut lumen.  Most likely, in 
the model some antigen is initially absorbed and then combines with IgA antibody 
within the extracellular fluid. The IgA in this case would lack secretory component, 
which is consistent with our observations and with the rarity of secretory component 
in human idiopathic IgA nephropathy (1, 2, 4). 
The  lack  of C3  deposition  in  glomeruli,  histologic  changes  such  as  mesangial 
proliferation or increased matrix, and hematuria/proteinuria are the major differences 
between this murine model and the human disease. Biopsies in humans are necessarily 
limited to instances in which clinical manifestations are apparent but such manifes- 
tations are quite variable.  Moreover, light microscopic changes are absent  in up to 
20% of the cases of the human disease, and complement is not always demonstrable 
(1).  Interestingly,  in  clinical  studies  that  assess  the  role  of  liver  disease  in  the 
pathogenesis of IgA nephropathy, an asymptomatic subpopulation has been identified 
(8-11, 29). If one accepts the immunopathological findings in such patients as within 
the spectrum of the disease, then the model described in this work corresponds to the 
more mild human cases. 
Differences in the chronicity of immune stimulation and the intensity and character 
of the immune response, or a  species difference in activation of complement with its 
phlogogenic sequelae, might account  for some of the differences noted between the 
model and the typical human disease.  In the model there may be a  prolonged low 
dose of exogenous antigenic stimulation as opposed to the intense acute exposure to 
antigen that could occur with intramucosal infection.  Moreover, during infection a 
replicating agent could elicit a  more pronounced antibody response, and because of 
the invasive properties of infectious agents, they or their shed antigens could penetrate 
the mucosal surface, enter the interior of the body, and  elicit  an  IgG and/or  IgM 
component to the response. 
The biologic mechanisms underlying proteinuria, hematuria, and the proliferation 
of glomerular cells  and  matrix  are currently  unclear.  Generally the  factors which 
modulate  immunologic  injury  are  labile.  If this  holds  true  for  immunologically 
mediated renal injury, whether consequent to immune complex deposition, comple- 
ment  deposition,  or  some  combination,  then  the  rate  as  well  as  the  amount  of 
deposition of immune reactants would be significant. The contrast between a presum- 580  EXPERIMENTAL IgA NEPHROPATHY 
ably  rapid,  intense  aggregation  and  deposition  of immune  complexes during  the 
course  of an  intramucosal  infection  vs.  the  gradual  protracted  immune  complex 
deposition in the model could then be expressed as the distinction between the injury 
usually seen in human IgA nephropathy and the seemingly more mild changes in the 
model. 
Complement deposition may or may not fully account for the histologic changes 
and/or hematuria and  proteinuria in  the human  disease.  The lack of complement 
deposition in the glomeruli of immunized mice in these studies, whether accounting 
for  the  lack  of other  findings  or  not,  is  the  major  immunopathologic  difference 
between the model and human  IgA nephropathy.  Several factors may explain this 
difference.  Slow  deposition  of antibody  in  a  chronic  time  course  might  limit  the 
positive  feedback  component  of the  alternative  pathway  C3  convertase,  thereby 
limiting complement deposition. In two previous studies of experimental murine IgA 
nephropathy, Rifai et al.  (27)  injected large (milligram range)  doses of antigen and 
specific antibody, and Isaacs et al. (30) injected doses of antigen (milligram range) in 
an active model. Both studies reported C3 deposition in the glomeruli in a distribution 
similar  to  that  of IgA.  Parenteral  administration  of comparatively large  doses  of 
immune reactants  in  these studies distinguishes them  from our work.  Although  we 
have  shown  that  enteric administration  of antigen  can  lead  to  immune  complex 
deposition in the kidney, the rate of deposition would be expected to be less under the 
conditions of our model. 
Second, there is evidence that immune complexes containing only IgA antibody fix 
complement by the alternative pathway but  that  this complement fixation  (in the 
mouse) is limited to the fluid phase  (31), whereas complexes with some IgG or IgM 
can result  in  the full activation of the membrane attack complex. The apparently 
pure IgA  immune response observed in  our model of IgA  nephropathy, compared 
with the usual admixture of IgG and/or IgM in the human disease, might account for 
the differences in C3  deposition.  More fulminant  mucosal antigenic exposure with 
penetration of antigen into the extracellular fluid could lead to an associated IgG or 
IgM  antibody  response,  which  would  favor  C3  deposition.  This  idea  is  further 
supported by the observations of some authors that codeposition of IgG and/or IgM 
in humans correlates with a  more severe disease (4-7,  12). Finally, species differences 
in the capacity of pure IgA immune complexes to promote full complement fixation 
may exist between mice and men. 
An additional difference in the immunopathological findings in this study vs. the 
human disease relates to the polymerization of the IgA. Although all the IgA deposits 
in our experiments contained J  chain, which indicates that at least some of the IgA 
was dimeric or oligomeric, J  chain has not been described in the human disease (1). 
The higher percentage of IgA dimers and oligomers in normal mouse serum compared 
with human serum (32) could account for this. 
The  model  used  here  affords  a  basis  for  further  study  of the  mechanisms  and 
determinants  of glomerular immune  deposits  in  IgA  nephropathy.  By altering the 
rate, dose, and nature of the antigenic stimulation and the method of immunization, 
by effecting changes in the natural tissue handling of IgA and IgA immune complexes, 
and by more precisely quantifying immune reactants localized to glomeruli, it should 
be  possible  to  identify the  most  significant  factors  which  promote  or  retard  IgA 
immune deposits and to elucidate the mechanisms by which these deposits form. EMANCIPATOR,  GALLO, AND LAMM  581 
Summary 
To test  the hypothesis that  IgA nephropathy can result  from a  mucosal immune 
response, mice were orally immunized with one of three protein antigens  for  14 wk. 
Such mice exhibited an essentially pure mucosal antibody response characterized by 
specific IgA-producing plasma  cells  in exocrine sites  and  specific IgA antibodies  in 
serum.  Furthermore,  73%  of immunized  mice  had  IgA and  88%  had  immunogen 
deposited  in  the  glomerular  mesangium,  and  64%  of immunized  mice  examined 
ultrastructurally  had electron-dense mesangial  deposits.  All three were present  con- 
currently in 57% of the immunized mice. No differences in regard to IgG or IgM were 
observed between immunized and control mice for any of these parameters.  Mucosal 
immunization  therefore  can  result  in  a  specific  immune  response  that  leads  to 
mesangial  deposition  of immune  complexes containing IgA antibody.  In its  funda- 
mental features the experimental renal lesion resembles that seen in the human disease 
IgA nephropathy. 
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